Blood cancers

CLL patients now less likely to have severe COVID-19 outcomes

People with COVID-19 are now less likely to have severe or fatal outcomes from COVID-19 disease compared to the early stages of the pandemic, an international study has shown. COVID-19 case fatality rates dropped from 35% to 11% and hospitalisation rates fell from 85% to 55% for patients with CLL between the early and later ...

Already a member?

Login to keep reading.

© 2021 the limbic